Gupta Suneel
Insider CIK 1763923 · PTGX EVP Clinical Operations
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2024-11-26 | 2024-11-27 | 30,000 | — | $0 | 93,750 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2024-11-26 | 2024-11-27 | 450 | — | $0 | 93,300 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2024-11-26 | 2024-11-27 | 450 | $12.17 | $5.5K | 267,433 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2024-11-26 | 2024-11-27 | 30,000 | $12.17 | $365.1K | 286,174 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2024-11-26 | 2024-11-27 | 19,191 | $45.50 | $873.2K | 266,983 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2024-11-25 | 2024-11-27 | 45,000 | — | $0 | 0 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2024-11-25 | 2024-11-27 | 45,000 | — | $0 | 0 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2024-11-25 | 2024-11-27 | 85,000 | — | $0 | 0 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2024-11-25 | 2024-11-27 | 45,000 | $7.38 | $332.1K | 229,611 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2024-11-25 | 2024-11-27 | 45,000 | $8.02 | $360.9K | 274,611 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2024-11-25 | 2024-11-27 | 85,000 | $7.80 | $663.0K | 359,611 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2024-11-25 | 2024-11-27 | 103,437 | $46.04 | $4.76M | 256,174 | SEC↗ |
| PTGX Protagonist Therapeutics, | F Tax w/h | 2024-02-26 | 2024-02-28 | 4,282 | $29.53 | $126.4K | 183,285 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2024-01-09 | 2024-01-11 | 5,000 | — | $0 | 45,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2024-01-09 | 2024-01-11 | 5,000 | $25.00 | $125.0K | 187,567 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2024-01-09 | 2024-01-11 | 5,000 | $7.38 | $36.9K | 192,567 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2024-01-02 | 2024-01-04 | 71,500 | — | $0 | 71,500 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award | 2024-01-02 | 2024-01-04 | 19,250 | — | $0 | 187,567 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2023-10-19 | 2023-10-23 | 20,000 | — | $0 | 50,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2023-10-19 | 2023-10-23 | 20,000 | $7.38 | $147.6K | 168,317 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award | 2023-05-31 | 2023-06-02 | 12,000 | — | $0 | 152,187 | SEC↗ |
| PTGX Protagonist Therapeutics, | F Tax w/h | 2023-05-31 | 2023-06-02 | 4,150 | $26.07 | $108.2K | 148,037 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2023-01-16 | 2023-01-18 | 123,750 | — | $0 | 123,750 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award | 2023-01-16 | 2023-01-18 | 20,625 | — | $0 | 138,187 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2022-04-26 | 2022-04-26 | 40,000 | — | $0 | 70,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2022-04-26 | 2022-04-26 | 40,000 | $7.38 | $295.2K | 117,561 | SEC↗ |
| PTGX Protagonist Therapeutics, | F Tax w/h | 2022-02-28 | 2022-03-02 | 649 | $24.28 | $15.8K | 77,007 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2022-02-15 | 2022-02-17 | 75,000 | — | $0 | 75,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award | 2022-02-15 | 2022-02-17 | 12,500 | — | $0 | 77,656 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2021-02-26 | 2021-02-26 | 80,000 | — | $0 | 80,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award | 2021-02-26 | 2021-02-26 | 12,000 | — | $0 | 63,987 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2020-02-28 | 2020-02-28 | 85,000 | — | $0 | 85,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | P Buy | 2019-12-03 | 2019-12-03 | 30,000 | $5.13 | $153.9K | 49,500 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2019-02-28 | 2019-03-04 | 45,000 | — | $0 | 45,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award | 2019-02-28 | 2019-03-04 | 7,500 | — | $0 | 17,500 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2019-01-15 | 2019-01-16 | 110,000 | — | $0 | 110,000 | SEC↗ |